Viewing StudyNCT04050436

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 1:32 PM
Last Modification Date: 2024-10-26 @ 1:15 PM
Study NCT ID: NCT04050436
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-02
First Post: 2019-08-02
Brief Title: Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer
Sponsor: Replimune Inc
Organization: Replimune Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Metastatic Cutaneous Squamous Cell Carcinoma
Cutaneous Squamous Cell Carcinoma
Advanced Cutaneous Squamous Cell Carcinoma
Keywords:
Name View
Oncolytic Virus View
Carcinoma View
Carcinoma Squamous Cell View
Cemiplimab View
Metastatic Cutaneous Squamous Cell Carcinoma View
Oncolytic Immuno-gene therapy View